News

• FDA accepts Dupixent® (dupilumab) for review in children with moderate-to-severe asthma
  03/04/2021 / 07:00 - GlobeNewswire
•  
• EMA extends use advice for Regeneron COVID mix
  02/26/2021 / 12:28 - TeleTrader
•  
• Ziopharm Oncology Provides Leadership and Corporate Updates; Reports Fourth Quarter and Full Year 2020 Financial Results
  02/25/2021 / 22:05 - GlobeNewswire
•  
• Europe closes lower amid recovery uncertainties
  02/25/2021 / 17:31 - TeleTrader
•  
• Regeneron: COVID cocktail has clear efficacy
  02/25/2021 / 14:13 - TeleTrader
•  
• Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results
  02/25/2021 / 13:30 - GlobeNewswire
•  
• Decibel Therapeutics Presents Promising Preclinical Findings on DB-OTO, Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin Mutations
  02/24/2021 / 13:00 - GlobeNewswire
•  
• Kiniksa Reports Fourth Quarter and Full-Year 2020 Financial Results and Corporate and Pipeline Activity
  02/23/2021 / 14:00 - GlobeNewswire
•  
• FDA approves Libtayo® (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50%
  02/22/2021 / 19:00 - GlobeNewswire
•  
• ASLAN Pharmaceuticals Appoints Dr Neil Graham as Independent Director
  02/18/2021 / 13:00 - GlobeNewswire
•  
• Ziopharm Oncology to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast on February 25, 2021
  02/16/2021 / 22:01 - GlobeNewswire
•  
• The Lancet publishes Libtayo® (cemiplimab) data showing extended overall survival in patients with first-line advanced non-small cell lung cancer with PD-L1 expression of ³50%
  02/12/2021 / 07:00 - GlobeNewswire
•  
• FDA approves Libtayo® (Cemiplimab-rwlc) as first immunotherapy indicated for patients with advanced basal cell carcinoma
  02/09/2021 / 23:15 - GlobeNewswire
•  
• Regeneron to deliver 750K therapy doses to US by July
  02/05/2021 / 15:53 - TeleTrader
•  
• Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors
  02/05/2021 / 15:00 - GlobeNewswire